Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
Clinical trial NCT02451982 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02451982
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-28
- Primary completion
- 2026-09-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.